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Central message: Despite progress is being made in lowering in-hospital mortality rates 20 
among the major racial/ethnic groups, ethnical disparities in hospital mortality after coronary 21 
bypass surgery remain.   22 
 3 
 
Prospective statement: The effect of race on mortality after coronary bypass surgery 23 
remains uncertain and current guidelines and risk stratification systems make no 24 
differentiation by race. We showed that despite progress is being made in lowering in-25 
hospital mortality rates among the major racial/ethnic groups, ethnical disparities in hospital 26 
mortality after CABG remain.   27 
 4 
 
ABBREVIATIONS 28 
CABG: coronary artery bypass grafting  29 
CI: confidence interval 30 
OR: odds ration 31 
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Abstract 33 
Background: Despite several reports, there are still conflicting data on the influence of 34 
ethnicity on mortality rates associated with coronary artery bypass grafting (CABG). We aimed 35 
to get further insights into the effect of race on mortality following CABG by performing a risk 36 
adjusted meta-analysis.   37 
Methods: Relevant studies were searched on PubMed, Embase, BioMed Central, and the 38 
Cochrane Central register. Pairwise meta-analysis was used to estimate the relative risk of 39 
hospital death of black, Hispanic and Asiatic patients using White patients as reference. Risk 40 
adjusted meta-analytic estimates were obtained using generic inverse variance methods with 41 
random effect model.  42 
Results: A total of twenty-eight studies were selected for analysis. A total of twenty-one 43 
studies reported on hospital mortality in Black (n=222,892) versus White (n=3,884,043) 44 
patients, seven studies reported on Hispanic (n=91,256) versus White (n= 1,458,524) and nine 45 
studies reported on Asiatic (n=27,820) versus White (n=1,081,642).  When compared to White 46 
patients, adjusted risk of hospital death was significantly higher for Black patients (adjusted 47 
OR 1.25; 95%CI 1.13-1.39; P<0.001), and not statistically different for Asiatic (OR 1.33; 48 
95%CI 0.99, 1.77; P=0.05) and Hispanic patients (adjusted OR 1.08; 95%CI 0.94- 1.23; 49 
P=0.26). Meta-regression showed a significant trend towards lower mortality rates in most 50 
recent series in both Blacks (P=0.02) and Whites (P=0.0007) and Asiatic (P=0.01) but not for 51 
Hispanic (P=0.41). However, as mortality rates were lower across the different races, the 52 
relative disadvantage between the study groups persisted, which may explain the lack of 53 
interaction between study period and race effect on mortality for Black (adjusted P=0.09), 54 
Asiatic (adjusted P=0.63) and Hispanic (adjusted P=0.97). 55 
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Conclusions: The present meta-analysis showed that despite progress is being made in 56 
lowering in-hospital mortality rates among the major racial/ethnic groups, ethnical disparities 57 
in hospital mortality after CABG remain.  58 
Introduction 59 
Although multiple studies have found that non-White patients, in particular Black and 60 
Hispanic, have lower rates of cardiovascular procedures, including cardiac catheterization, 61 
percutaneous coronary intervention, and coronary artery bypass grafting (CABG) [1], there are 62 
still limited and conflicting data on the influence of ethnicity on mortality and complication 63 
rates associated with CABG [2-6]. One potential concern is that if racial minorities are less 64 
likely to be referred for cardiac catheterization and coronary revascularization, then only those 65 
with particularly advanced disease or compelling indications may undergo these procedures, 66 
leading to worse outcomes [2-4]. Previous studies evaluating the impact of ethnicity on 67 
mortality following CABG surgery have had mixed conclusions. Several studies have reported 68 
higher mortality for Black patients following the operation [5,6]. Other studies, have suggested 69 
similar risk adjusted survival for Black patients following CABG surgery [2-4]. Therefore, the 70 
effect of race on mortality after CABG remains uncertain [2] and current CABG guidelines [7] 71 
and risk stratification systems [8,9] make no differentiation by race. We aimed to get further 72 
insights into the effect of race on mortality following CABG by performing a risk adjusted 73 
meta-analysis of comparative studies.   74 
Methods 75 
Literature Search Strategy 76 
The search strategy adopted is in accordance with the Meta-analysis of Observational Studies 77 
in Epidemiology guidelines [10]. We searched PubMed, the Cochrane Central Register of 78 
Controlled Trials, and EMBASE from their inception to March 2017, without language 79 
restrictions. Search algorithm used was "race" OR "ethnicity” AND ("coronary artery bypass" 80 
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OR CABG OR "bypass surgery" OR "coronary bypass"). In addition, reference lists of the 81 
identified reports and relevant reviews were manually screened by 2 reviewers (UB, MK) to 82 
identify relevant studies. Studies reporting hospital outcomes after CABG across different 83 
ethnical groups including White, Black, Hispanic and Asiatic were selected. When centres have 84 
published duplicate trials with accumulating numbers of patients, only the largest reports were 85 
included for qualitative appraisal. Non-English articles were not excluded. Abstracts, case 86 
reports, conference presentations, editorials, and expert opinions were excluded. 87 
Disagreements were resolved by consensus. The quality of included studies was assessed with 88 
the Newcastle-Ottawa scale for observational studies [11]. The total score was 9 stars, and the 89 
quality was graded as low level (<6 stars) or high level (≥6 stars). Baseline characteristics and 90 
hospital outcomes in different ethnical groups were independently abstracted by 2 investigators 91 
(UB, MK). The primary outcome of the present meta-analysis was hospital mortality. Hospital 92 
mortality crude incidence rate for different ethnical groups were obtained from individual 93 
studies. As different ethnical groups can present different patient level and hospital level factors 94 
distribution, we also extracted fully adjusted estimates obtained by multivariate models from 95 
individual studies. Other operative outcomes investigated were: stroke, wound infection, renal 96 
failure/dialysis, re-exploration for bleeding, respiratory failure/tracheostomy.  97 
Statistical analysis 98 
Pairwise meta-analysis methods were used to estimate operative mortality relative risk for 99 
different ethnical groups (Black, Hispanic and Asiatic) using White group as reference. A 100 
subgroup analysis was done to compare South Asian to White. Individual study and pooled 101 
operative mortality was reported as odds ratio (OR) with a 95% confidence interval (CI). 102 
Unadjusted pooled estimates were obtained using DerSimonian and Laird model [12].  103 
Individual studies risk-adjusted estimates were pooled as log OR and standard error (SE) using 104 
generic inverse variance method [13]. Random effect was used in all meta-analyses to obtain 105 
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more conservative estimates [14] We used the I2 statistic, which estimates the percentage of 106 
total variation across studies that is due to heterogeneity rather than chance. Suggested 107 
thresholds for heterogeneity were used, with I2 values of 25–49%, 50–74% and ≥75%, 108 
indicative of low, moderate and high heterogeneity [15, 16]. For each study, median year of 109 
enrolment was obtained and changes in estimates across different eras were tested using meta-110 
regression model (Mixed-Effects Model). Meta-analytic estimates were computed using 111 
Review Manager (RevMan, Computer program. Version 5.2. Copenhagen: The Nordic 112 
Cochrane Centre, The Cochrane Collaboration, 2012) and meta R package (R Core Team 113 
(2016). R: A language and environment for statistical computing. R Foundation for Statistical 114 
Computing, Vienna, Austria. URL https://www.R-project.org/). 115 
Results 116 
Study selection  117 
A total of 1362 references were identified through electronic database searches and references 118 
lists. After exclusion of duplicate or irrelevant references, 45 potentially relevant articles were 119 
retrieved. After detailed evaluation of these articles, 28 studies were selected for analysis [2-120 
6,16-38] (Figure). Study overview, patients’ characteristics and severity of coronary artery 121 
disease are reported in Table 1, Table 2 and Supplementary Table 1, respectively. A total of 122 
twenty-one studies reported on hospital mortality in Black (n=222,892) versus White 123 
(n=3,884,043) patients, seven studies reported on Hispanic (n=91,256) versus White (n= 124 
1,458,524) and nine studies reported on Asiatic (n=27,820) versus White (n=1,081,642). Of 125 
the nine studies that reported on Asiatic patients, five studies reported on South Asians, one 126 
study reported on South Asians and Chinese, and three studies did not distinguish between the 127 
different Asiatic ethnicities.  Fully adjusted estimates including patients level and hospital level 128 
covariates were reported by 12 studies for Black vs White comparison, 4 studies for Hispanic 129 
vs White comparison and 4 studies for Asiatic vs White comparison.  The methods and 130 
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variables used in adjustment are listed in Supplementary Table 2. Quality assessment of 131 
individual studies is reported in Table 3.  132 
Meta-analysis  133 
Meta-analysis of unadjusted rates (Figure 2) showed that when compared to White patients, 134 
Black (unadjusted OR 1.24; 95%CI 1.20-1.28; P<0.001) and Asiatic patients (unadjusted OR 135 
1.33; 95%CI 1.05-1.69; P=0.02) were associated with a significantly increased risk for hospital 136 
death while Hispanic presented a comparable risk (unadjusted OR 0.98; 95%CI 0.87-1.09; 137 
P=0.66). This trend was confirmed when reported adjusted estimates for hospital mortality 138 
were pooled (Figure 3). When compared to White patients, adjusted risk of hospital death was 139 
significantly higher for Black patients (adjusted OR 1.25; 95%CI 1.13-1.39; P<0.001), and not 140 
statistically different for Asiatic (OR 1.33; 95%CI 0.99, 1.77; P=0.05) and Hispanic patients 141 
(adjusted OR 1.08; 95%CI 0.94- 1.23; P=0.26).  142 
A subgroup analysis showed that South Asians had higher risk of crude hospital mortality 143 
compared to Whites (unadjusted OR 1.72; 95%CI 1.12-2.66; P=0.01). However, there was no 144 
difference in the risk of hospital mortality between South Asians and Whites after adjusting for 145 
possible confounding factors (adjusted OR: 1.73; 95%CI 0.71-4.18; P=0.23) (Supplementary 146 
Figure 1).  147 
Meta-regression (Figure 4) showed a significant trend towards lower mortality rates in most 148 
recent series in both Blacks (P=0.02) and Whites (P=0.0007) and Asiatic (P=0.01) but not for 149 
Hispanic (P=0.41). However, as mortality rates were lower across the different races, the 150 
relative disadvantage between the study groups persisted, which may explain the lack of 151 
interaction between study period and race effect on mortality for Black (unadjusted P=0.29, 152 
adjusted P=0.09), Asiatic (unadjusted P=0.15, adjusted P=0.63) and Hispanic (unadjusted and 153 
adjusted P=0.97).  154 
 155 
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Postoperative complications 156 
For the comparison between Blacks and Whites, several studies reported also on unadjusted 157 
rate of postoperative complication (Supplementary Figure 2). Pooled estimates showed that 158 
rate for stroke (unadjusted OR 1.78; 95%CI 1.49-2.13; P<0.001), bleeding (unadjusted OR 159 
1.24; 95%CI 1.09-1.41), tracheostomy/reintubation (unadjusted OR 1.37; 95%CI 1.15, 1.61; 160 
P=0.0003) and renal failure (adjusted OR 1.54; 95%CI 1.38-1.73; P<0.001) but not wound 161 
infection (OR1.16; 95%CI 0.98- 1.36; P=0.09) were higher among Black patients.   162 
Discussion 163 
In the present study, we investigated the effect of race by performing a meta-analysis and meta-164 
regression of comparative studies available. We showed that Black race was associated with 165 
increased mortality rates when compared to White race also after adjusting for patient-level 166 
and hospital-level factors. We also showed that despite mortality rates declined over the years 167 
for Black patients, a specular reduction in mortality was observed for White patients. Therefore 168 
the gap between Black and White patients remained stable. Black race was also shown to be 169 
associated with significant increased risk of postoperative complications including bleeding, 170 
stroke, renal failure/dialysis and respiratory failure/tracheostomy. Although not statistically 171 
significant, there was a strong trend towards an increased risk of mortality in Asiatic when 172 
compared to White subjects (P =0.05). On the other hand, Hispanics were consistently found 173 
to have mortality rates comparable to those observed in Whites without significant changes 174 
across different eras.  175 
Despite several studies have suggested ethnical disparities in operative outcomes following 176 
CABG [5,6] final conclusions are still lacking and current CABG guidelines and risk 177 
stratification systems including the Society of Thoracic Surgeons (STS scoring system) 178 
(http://riskcalc.sts.org/stswebriskcalc/) [8] and the European System for Cardiac Operative 179 
Risk Evaluation (Euroscore) (http://www.euroscore.org/) [9] make no differentiation by race 180 
 11 
 
in terms of operative mortality. The present study consistently demonstrated that Black patients 181 
remain associated with a higher operative mortality although this disparity was found to be 182 
relevant only among males.  183 
There are a number of possible explanations for these persistent differences in outcomes 184 
between the different racial groups. First, it is well documented that disparities in access to 185 
health care system persist by race and Black patients are likely to be referred to surgery with 186 
poorer health conditions [39-40]. While the present NIS analysis and meta-analysis controlled 187 
for many more patient, organizational and socioeconomic aspects of CABG patients' condition, 188 
there still may be other unmeasured social phenomena of the patient's background, health 189 
condition or hospital stay that may help explain racial/ethnic differences. In addition, many 190 
aspects of the physician-patient relationship that involve patients' education, trust and the 191 
physician's sensitivity to a patient's culture might also play a critical role [40]. Finally, others 192 
have identified genetic differences in race/ethnicity that could account for differences in 193 
outcomes. For patients with heart disease, some studies have suggested subtle differences 194 
among race/ethnicities in the biology of hypertension. Potential differences in the biology of 195 
hypertension may result in more frequent and more severe hypertension and ventricular 196 
hypertrophy in Black patients [41]. 197 
The present meta-analysis presents several limitations. The vast majority of the included 198 
studies didn’t mention the definitions used for race identification, a factor that may have 199 
influenced the results. Although we performed a risk-adjusted analysis, we cannot exclude the 200 
presence of residual confounding factors accounting for differences in outcomes between 201 
ethnical groups, which may have not been considered by individual studies. In particular, data 202 
on predicted risk of mortality (i.e. SYNTAX score) were not provided in most of the studies. 203 
Moreover, detailed information on patients’ socioeconomic status and surgeon and hospital 204 
volume were limited. The study focused primarily on operative mortality and did not compare 205 
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the differences in long-term outcomes between the different race groups. Most of the series 206 
included in the present analysis were from US databases and this might partially limit the 207 
generalizability of the present findings. In addition, despite we attempt to avoid cohort 208 
overlapping among different studies, we cannot exclude that different US nationwide databases 209 
might have reported on similar study populations.  Finally, we acknowledge the difficulties and 210 
uncertainties that may sometimes be associated with defining individual patients’ ethnicities, 211 
particularly for those residing in North America where the population diversity may lead to 212 
racial mixing.  213 
In conclusion, the present meta-analysis confirmed that despite progress is being made in 214 
lowering in-hospital mortality rates among the major racial/ethnic groups including Black 215 
patients, significant disparities in outcomes still remains and these warrant further 216 
investigation. 217 
Sources of Funding: None 218 
Disclosures: None  219 
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Figure Legend 340 
Central picture: Meta-analytic risk-adjusted estimates of race effect on operative mortality 341 
(White as reference) 342 
Figure 1. Study selection process for meta-analysis  343 
Figure 2. Meta-analytic unadjusted estimates of race effect on operative mortality (White as 344 
reference) 345 
Figure 3. Meta-analytic risk-adjusted estimates of race effect on operative mortality (White as 346 
reference) 347 
Figure 4.  Meta-regression of crude mortality rate in separate ethnical groups and race effect 348 
on mortality across different study periods (median year of enrolment).  349 
Supplementary Figure 1. Meta-analytic unadjusted and adjusted risk of operative mortality in 350 
South Asians compared to Whites. 351 
Supplementary Figure 2. Meta-analytic estimates of unadjusted effect of Black vs White race 352 
on postoperative complications.   353 
  19 
Table 1. Overview of studies included in the meta-analysis  
N of study First author 
and year of 
publication 
Country Single vs  
multi-institution 
Years of  
enrolment 
Information on source of data White 
Patients 
(N) 
Black 
patients  
(N) 
Asiatic 
patients 
(N) 
Hispanic 
Patients 
(N) 
Race identification 
1 Anderson 
2016 
USA 
multi-institution 2011-2012 
California CABG   Reporting 
Program 
14389 975 3196 4614 * 
2 Andrews 
2015 
USA 
multi-institution 2009 
Healthcare Research and 
Quality (NIS) 
194440 15534   * 
3 Becker 2006 USA 
multi-institution 1993-2002 
Healthcare Research and 
Quality (NIS) 
1040641 63991 20353 67554 * 
4 Bridges 2000 USA 
multi-institution 1994-1997 
Society of Thoracic Surgeons 
(STS) 
555939 25850   Self-identified 
5 Brister 2007 Canada 
Single institution 1994-2003 - 917  917  
Self-identified & patients’ 
name 
6 Chowdhury 
2016 
USA 
Single institution 2006-2010 - 3107 389   Self-identified 
7 Cooper 2009 USA 
multi-institution 1997-2007 
Society of Thoracic Surgeons 
(STS) 
10841 2033   * 
8 Efird 2015 USA Single institution 1992-2011 - 11395 2379   Self-identified 
9 Gasevic 2013 Canada 
multi-institution 1999-2003 
British Columbia Cardiac 
Registry 
1507  180  Patients’ name 
10 Goldsmith 
1999 
UK 
Single institution 1994-1997 - 190  194  * 
11 Gray 1996 USA Single institution 1984-1992 - 3113 115   * 
12 Hadjinikolaou 
2010 
UK 
Single institution 2002-2007 - 2623  274  Self-identified 
13 Kaila 2014 Canada multi-institution 1999-2012 APPROACH database 737  252  Patients’ name 
14 Keeling 2016 USA Single institution 2002-2014 - 13569 2810   * 
15 Kim 2008 USA 
multi-institution 2002-2005 
University HealthSystem 
Consortium 
63487 8462   * 
16 Konety 2005 USA 
multi-institution 1997-2000 
Medicare Provider and 
Analysis Review 
566785 24354   * 
17 Lucas 2006 USA/Canada 
multi-institution 1994-1999 
Medicare Provider and 
Analysis Review 
829037 33367   * 
18 Maynard 
2001 
USA 
multi-institution 1994-1999 Veteran Affair 27439 2380   * 
19 Mehta 2016 USA 
multi-institution 2010-2011 
Society of Thoracic Surgeons 
(STS) 
136362 14375   * 
20 O’Neal 2014 USA Single institution 2002-2011 - 3460 970   Self-identified 
21 Pollock 2015 USA Single institution 2004-2011 - 6365 612  593 * 
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22 Rangrass  
2014 
USA 
multi-institution 2007-2008 
Medicare Analysis Provider 
and Review 
159043 9390  3016 * 
23 Rumsfeld 
2002 
USA 
multi-institution 1995-2001 Veteran Affair 29333 2570  1525 * 
24 Smith 2006 USA multi-institution 1993-2005 multi-institutional database 1932 644   * 
25 Trivedi 2006 USA 
multi-institution 1998-2001 
Healthcare Research and 
Quality (NIS) 
193684 11393  11393 * 
26 Yeo 2007 USA 
multi-institution 2003 
California CABG Outcomes 
Reporting Program 
15069 785 1772 2561 * 
27 Zacharias 
2005 
USA 
Single institution 1991-2003 - 6073 304   * 
28 Zindrou 2001 UK Single institution 1993-1997 - 1458  436  Self-identified 
* As reported in single / multiple institutional or national databases 
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Table 2. Patients’ characteristics in studies included in the meta-analysis  
 Mean Age (years) % Female % Diabetes Mellitus 
Study White Black Asiatic Hispanic White Black Asiatic Hispanic White Black Asiatic Hispanic 
Anderson 2016             
Andrews 2015         27.10% 42.60%             
Becker 2006         28.40% 44% 27.70% 31.40%         
Bridges 2000 65 62     27.93% 44.45%     27.82% 43.78%     
Brister 2007 62   61   23.50%   23.60%   37.30%   39.40%   
Chowdhury 2016 58 56     10% 21%             
Cooper 2009 63 60     27% 42%     33.60% 47.00%     
Efird 2015 65 62     27.30% 42%     32.00% 48.00%     
Gasevic 2013         21%   18%   21.30%   31.00%   
Goldsmith 1999 58   58           11.60%   38.70%   
Gray 1996 67 65     21% 35%     23.00% 36.00%     
Hadjinikolaou 2010 66   63   19.70%   23%           
Kaila 2014         20.30%   21.40%   47.80%   44.40%   
Keeling 2016 64 61             37.10% 50.30%     
Kim 2008                         
Konety 2005 74 72     34.40% 51.40%     8.30% 18.40%     
Lucas 2006         34.30% 51.50%             
Maynard 2001 64 63     1% 1%     30.00% 34.00%     
Mehta 2016 66 62     25.30% 40.40%     39.10% 53.00%     
O’Neal 2014 64 61     25% 38%     37.20% 50.00%     
Pollock 2015 65 62   61 23.70% 44%   27.50% 37.10% 46.60%   61.20% 
Rangrass  2014 74       30.50%       29.30%       
Rumsfeld 2002 63.6 62.2   63.8 1.10% 1.10%   0.50% 31.40% 38.10%   47.80% 
Smith 2006 64.6 63.7     28.60% 45.70%     30.40% 47.20%     
Trivedi 2006                         
Yeo 2007 66.91 63.17 65.6 64.02 25% 43% 27% 31% 33.00% 49.00% 47.00% 56% 
Zacharias 2005 64 62     29.80% 46.10%     32.40% 43.40%     
Zindrou 2001 61.6   59.6   15.98%   19.70%   17.50%   43.00%   
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Table 3. Study quality assessment using New Castle Ottawa Scale 
Study Selection Comparability Exposure Sum 
Anderson 2016 4 2 3 9 
Andrews 2015 4 2 3 9 
Becker 2006 4 0 3 7 
Bridges 2000 4 0 3 7 
Brister 2007 4 2 3 9 
Chowdhury 2016 4 0 3 7 
Cooper 2009 4 2 3 9 
Efird 2015 4 0 3 7 
Gasevic 2013 4 0 3 7 
Goldsmith 1999 4 0 3 7 
Gray 1996 4 2 3 9 
Hadjinikolaou 2010 4 0 3 7 
Kaila 2014 4 2 3 9 
Keeling 2016 4 2 3 9 
Kim 2008 4 2 3 9 
Konety 2005 4 2 3 9 
Lucas 2006 4 2 3 9 
Maynard 2001 4 2 3 9 
Mehta 2016 4 2 3 9 
O’Neal 2014 4 0 3 7 
Pollock 2015 4 0 3 7 
Rangrass  2014 4 2 3 9 
Rumsfeld 2002 4 2 3 9 
Smith 2006 4 0 3 7 
Trivedi 2006 4 2 3 9 
Yeo 2007 4 0 3 7 
Zacharias 2005 4 2 3 9 
Zindrou 2001 4 0 3 7 
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Supplementary Table 1. Severity of coronary artery disease in studies included in the meta-analysis 
Study 
EF (%) Triple vessel disease (%) Left main coronary artery disease (%) 
EF 
expressed 
as 
White Black Oriental 
South 
Asian 
Hispanic White Black Oriental 
South 
Asian 
Hispanic White Black Oriental 
South 
Asian 
Hispanic 
Anderson 
2016 
                
Andrews 2015                 
Becker 2006                 
Bridges 2000 Mean  (SD) 51% (14) 48% (14)    70% 69%    20% 19%    
Brister 2007       76%   79%  22%   8%  
Chowdhury 
2016 
                
Cooper 2009 Mean 50% 49%         23% 20%    
Efird 2015       66% 68%    21% 21%    
Gasevic 2013       28%  28% 27%  3%  5% 3%  
Goldsmith 
1999 
Good EF 52%   56%  63%   66%       
Gray 1996       64% 68%    24% 22%    
Hadjinikolaou 
2010 
EF ≥ 30% 93%   95%            
Kaila 2014 EF >35% 72%   68%       7%   6%  
Keeling 2016 Mean (SD) 52% (12) 50% (13)              
Kim 2008                 
Konety 2005                 
Lucas 2006                 
Maynard 2001                 
Mehta 2016 Median 55% 53%    95% 94%    32% 29%    
O’Neal 2014       67% 68%    26% 27%    
Pollock 2015 Mean (SD) 49% (14) 47% (16)   47% (14)      29% 28%   29% 
Rangrass  
2014 
                
Rumsfeld 2002 EF >35% 89% 87%   88% 72% 73%   76%      
Smith 2006 EF >40% 78% 75%              
Trivedi 2006                 
Yeo 2007 EF >30% 92% 89%   89% 77% 77%   78% 24% 23%   23% 
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Zacharias 2005 Mean (SD) 50% (11) 49% (12)    72% 73%    19% 18%    
Zindrou 2001 EF >35% 88%   85%       1%   1%  
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Supplementary Table 2. Methods and variables used in adjusting for hospital mortality  
Study 
Adjustment 
methods 
Adjustment variables 
Patient-level factors 
Hospital-
level factors 
 
Andrews 2015 
Logistic regression 
analysis 
Age, age-gender interaction, gender  
All patient 
refined DRG 
Becker 2006 
Logistic regression 
analysis 
Admission type, gender, insurance status, procedure 
characteristics, SES, smoking, year of procedure, 
cardiomyopathy, COPD, CHF, CLD, CRF, CVD, dysrhythmias, 
DM, HD, HTN, MI, obesity, previous CABG, PVD, RF, 
unstable angina, valve disease 
 
Brister 2007 
Logistic regression 
analysis 
Age, EF, HTN & unstable angina   
Cooper 2009 
Logistic regression 
analysis 
Age, anticoagulants, Beta blockers, BMI, BSA, diuretics, EF, 
gender, height, IABP, immunosuppressive therapy, 
inotropes, nitrates, last creatinine level, resuscitation, 
smoking, status, weight, cardiogenic shock, COPD, CVA, 
CVD, DM, HD, HF, HLD, HTN, left main disease, MI, number 
of diseased vessels, PVD, RF 
 
Gasevic 2013 
Logistic regression 
analysis 
Age, distance from nearest hospital, gender, SES, time from 
MI to revascularization, arrhythmia, ARF, cancer, 
cardiogenic shock, CHF, CRF, CVD, DM, Severity of CAD  
 
Hadjinikolaou 
2010 
Logistic regression 
analysis 
BMI, logistic Euroscore, DM, previous PCI  
Keeling 2016 
Logistic regression 
analysis 
Age, creatinine level, EF, gender, height, IABP, 
immunosuppressive therapy, resuscitation, single/multiple 
graft, status, weight, angina, arrhythmia, cardiogenic 
shock, COPD, CVD, DM, endocarditis, HF, HTN, MI, PAD, 
previous CV intervention, RF, valve disease 
 
Konety 2005 
Logistic regression 
analysis 
Admission priority, age, gender, SES, year of surgery, DM, 
CAD, CHF, COPD, CRF, CVD, HTN, PVD,  previous CABG or 
PCI 
 
Lucas 2006 
Logistic regression 
analysis 
Age, gender, SES, urgency of admission, year of operation, 
Charlson comorbidity score 
Hospital 
volume, 
clustering by 
hospital 
Maynard 2001 
Logistic regression 
analysis 
Age, IMA grafting, Deyo score, COPD, DM, HTN, MI  
Mehta 2016 
Logistic regression 
analysis 
Patient characteristics, surgeon, SES 
Hospital 
identity 
Rangrass  2014 
Logistic regression 
analysis 
Age, emergency admission, gender, SES, Elixhauser 
comorbidity index 
Hospital quality 
Rumsfeld 2002 
Linear regression 
analysis 
Age, BSA, EF, gender, IMA graft use, number of 
anastomoses, preoperative ECG, preoperative diuretics & 
IV nitroglycerin, preoperative IABP, priority of surgery, 
serum creatinine, smoking, CAD, COPD, CVD,DM, HTN, MI, 
NYHA class, preoperative mortality risk, previous heart 
surgery, prior PCI,   PVD, three vessel CAD 
 
Trivedi 2006 
Logistic regression 
analysis 
Age, gender, urgency of admission, COPD, CHF, DM, 
Elixhauser comorbidity index, PVD, HTN, MI 
Hospital 
volume & 
clustering by 
hospital 
Zacharias 2005 
Logistic regression 
analysis 
Age, Beta blockers, BSA, EF, gender, insurance status, 
preoperative IABP, priority of procedure, procedure 
characteristics, SES, smoking, arrhythmia, CHF, CVA, CVD, 
COPD, DM, double vessel disease, HLD, HTN, left main 
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disease, MI,  NYHA class, obesity, PVD, RF,  triple vessel 
disease, unstable angina. 
ARF: acute renal failure, BMI: body mass index, BSA: body surface area, CABG: coronary artery bypass graft, CAD: coronary 
artery disease, CHF: congestive heart failure, COPD: chronic obstructive pulmonary disease, CLD: chronic liver disease, CRF: 
chronic renal failure, CV: cardiovascular, CVA: cerebrovascular accident, CVD: cerebrovascular disease, DM: diabetes 
mellitus, DRG: diagnosis related group, HD: hemodialysis, HF: heart failure, HLD: hyperlipidemia, HTN: hypertension, IABP: 
intra-aortic balloon pump, IMA: internal mammary artery, IV: intravenous, MI: myocardial infarction, NYHA: New York 
Heart Association, PAD: peripheral arterial disease, PVD: peripheral vascular disease, RF: renal failure, SES: socioeconomic 
status 
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Central picture: Meta-analytic risk-adjusted estimates of race effect  
on operative mortality following CAGB (White as reference) 
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Figure 1. Study selection process for meta-analysis 
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Figure 2. Meta-analytic unadjusted estimates of race effect on operative mortality following CABG (White 
as reference) 
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Figure 3. Meta-analytic risk-adjusted estimates of race effect on operative mortality following CABG 
(White as reference) 
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Figure 4.  Meta-regression of crude mortality rate following CABG in the different ethnical groups and race 
effect on mortality across different study periods (median year of enrolment). 
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Supplementary Figure 1. Meta-analytic unadjusted and adjusted risk  
of operative mortality following CABG in South Asians compared to Whites. 
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Supplementary Figure 2. Meta-analytic point estimates of unadjusted effect  
of Black vs White race on postoperative complications following CABG. 
